Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ureta-Vidal

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 1999
Phenotypical and functional characterization of the CD8+ T cell repertoire of HLA-A2.1 transgenic, H-2KbnullDbnull double knockout miceA Ureta-Vidal, H Firat, B Pérarnau, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|February 18, 2004
[HTLV1 infection and pregnancy]G Carles, P Tortevoye, P Tuppin, et al.
The Journal of Experimental Medicine|February 9, 2000
Evidence for the chronic in vivo production of human T cell leukemia virus type I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptidesC Pique, A Ureta-Vidal, A Gessain, et al.
Journal of Virology|April 25, 2000
Lymphoid organs as a major reservoir for human T-cell leukemia virus type 1 in experimentally infected squirrel monkeys (Saimiri sciureus): provirus expression, persistence, and humoral and cellular immune responsesM Kazanji, A Ureta-Vidal, S Ozden, et al.
The Journal of Infectious Diseases|March 10, 2001
Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriersA Ureta-Vidal, C Pique, Z Garcia, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 1, 1995
Risk factors for maternal HTLV-I infection in French Guiana: high HTLV-I prevalence in the Noir Marron populationP Tuppin, J F Lepère, G Carles, et al.
European Journal of Immunology|October 10, 2001
Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic, H-2 class I KO miceH Firat, S Tourdot, A Ureta-Vidal, et al.
International Journal of Cancer|August 14, 1999
Mother-to-child transmission of human T-cell-leukemia/lymphoma virus type I: implication of high antiviral antibody titer and high proviral load in carrier mothersA Ureta-Vidal, C Angelin-Duclos, P Tortevoye, et al.
Nucleic Acids Research|December 26, 2001
The Ensembl genome database projectT Hubbard, D Barker, E Birney, et al.
Nucleic Acids Research|January 10, 2003
Ensembl 2002: accommodating comparative genomicsM Clamp, D Andrews, D Barker, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 1999
Phenotypical and functional characterization of the CD8+ T cell repertoire of HLA-A2.1 transgenic, H-2KbnullDbnull double knockout miceA Ureta-Vidal, H Firat, B Pérarnau, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|February 18, 2004
[HTLV1 infection and pregnancy]G Carles, P Tortevoye, P Tuppin, et al.
The Journal of Experimental Medicine|February 9, 2000
Evidence for the chronic in vivo production of human T cell leukemia virus type I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptidesC Pique, A Ureta-Vidal, A Gessain, et al.
Journal of Virology|April 25, 2000
Lymphoid organs as a major reservoir for human T-cell leukemia virus type 1 in experimentally infected squirrel monkeys (Saimiri sciureus): provirus expression, persistence, and humoral and cellular immune responsesM Kazanji, A Ureta-Vidal, S Ozden, et al.
The Journal of Infectious Diseases|March 10, 2001
Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriersA Ureta-Vidal, C Pique, Z Garcia, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 1, 1995
Risk factors for maternal HTLV-I infection in French Guiana: high HTLV-I prevalence in the Noir Marron populationP Tuppin, J F Lepère, G Carles, et al.
European Journal of Immunology|October 10, 2001
Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic, H-2 class I KO miceH Firat, S Tourdot, A Ureta-Vidal, et al.
International Journal of Cancer|August 14, 1999
Mother-to-child transmission of human T-cell-leukemia/lymphoma virus type I: implication of high antiviral antibody titer and high proviral load in carrier mothersA Ureta-Vidal, C Angelin-Duclos, P Tortevoye, et al.
Nucleic Acids Research|December 26, 2001
The Ensembl genome database projectT Hubbard, D Barker, E Birney, et al.
Nucleic Acids Research|January 10, 2003
Ensembl 2002: accommodating comparative genomicsM Clamp, D Andrews, D Barker, et al.
Pageof 2